ABVC BioPharma, Inc. Profile Avatar - Palmy Investing

ABVC BioPharma, Inc.

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for…

Biotechnology
US, Fremont [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

ABVC BioPharma, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

ABVC BioPharma, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of ABVC BioPharma, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of ABVC's Analysis
CIK: 1173313 CUSIP: 00091F106 ISIN: US00091F3047 LEI: - UEI: -
Secondary Listings
ABVC has no secondary listings inside our databases.